Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

President’s Proposed 2012 Budget Will Address Biomedical Innovation, But Details Are Lacking

This article was originally published in The Pink Sheet Daily

Executive Summary

In his annual State of the Union address, President Obama announced that his forthcoming federal budget proposal for 2012 will include policies to promote biomedical innovation, but did not describe what those policies would include.

You may also be interested in...



Consolidating Translational Research Programs Is Top FY '12 Priority For NIH

For National Institute of Health Director Francis Collins, the "major area of extraordinary opportunity" in his agency's fiscal 2012 budget proposal is a purportedly cost-neutral plan to pull together existing NIH-wide translational research programs under a new National Center for Advancing Translational Sciences.

Consolidating Translational Research Programs Is Top FY '12 Priority For NIH

For National Institute of Health Director Francis Collins, the "major area of extraordinary opportunity" in his agency's fiscal 2012 budget proposal is a purportedly cost-neutral plan to pull together existing NIH-wide translational research programs under a new National Center for Advancing Translational Sciences.

PhRMA's Policy Pitch: Protect Industry Innovation Or We Go The Way Of Auto Makers

Under new leadership, the Pharmaceutical Research and Manufacturers of America is making a strong pitch to Congress and the White House for regulatory and tax policy changes aimed at protecting innovation.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS071746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel